CN Stock MarketDetailed Quotes

603983 Guangdong Marubi Biotechnology

Watchlist
  • 27.32
  • +1.18+4.51%
Market Closed Sep 27 15:00 CST
10.96BMarket Cap35.90P/E (TTM)

Guangdong Marubi Biotechnology Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Guangdong Marubi Biotechnology Q2 2024 Earnings Date

Currency：CNYAug 24, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
753.41M
690.90M
-62.52M
Miss Est.
--
+18.58%
-8.30%
Net Income
--
66.40M
--
+26.54%
Analyst Rating
Buy

Sep 28, 2024

Guangdong Marubi Biotechnology Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 846.190M--
--2024/Q3-- / 616.834M--
Aug 24, 20242024/Q2690.900M / 753.415M--
--2023/Q4689.154M / 742.660M--
Oct 31, 20232023/Q3477.034M / 374.394M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 846.190M--
--2024/Q3-- / 616.834M--
Aug 24, 20242024/Q2690.900M / 753.415M--
--2023/Q4689.154M / 742.660M--
Oct 31, 20232023/Q3477.034M / 374.394M--

Unlock Free Earnings Estimates

Guangdong Marubi Biotechnology Earnings Reports

  • Guangdong Wanmei Biotechnology Co., Ltd.'s semi-annual report for 2024.

    Aug 23 12:00 ET

  • Summary of Guangdong Wanmei Biotechnology Co., Ltd.'s 2024 interim report

    Aug 23 12:00 ET

  • Guangdong Marumi Biotechnology Co., Ltd. 2024 First Quarter Report

    Apr 26 12:00 ET

  • Summary of the 2023 Annual Report of Guangdong Marumi Biotechnology Co., Ltd.

    Apr 26 12:00 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Sep 28, 2024

    Buy

    • Strong Buy

      42.31%

    • Buy

      57.69%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Latest Price
    % Chg

    No Data